Ajax-Loading

AstraZeneca PLC - Ebitda Interest Coverage

AstraZeneca PLC's Fiscal Year is From January To December.

The item "Ebitda-Interest-Coverage" stands at 9.30 as of 09/30/2025.

As of the end of AstraZeneca PLC's third quarter, the item "Ebitda Interest Coverage" stands at 9.30. This represents an increase of 14.97 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 6.44 percent compared to the value the year prior.
The 1 year change in percent is 6.44.
The 3 year change in percent is 43.01.

The Serie's long term average value is 7.95. It's latest available value, on 09/30/2025, is 16.89 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is +73.95%.
The Serie's change in percent from it's maximum value, on 12/31/2024, to it's latest available value, on 09/30/2025, is -5.46%.

Ebitda Interest Coverage for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Ebitda Interest Coverage905,699,262,464.00
LogoJohnson & Johnson - Ebitda Interest Coverage486,508,953,600.00
LogoAbbVie Inc - Ebitda Interest Coverage399,570,305,024.00
LogoRoche Holding AG - Ebitda Interest Coverage317,433,206,677.55
LogoNovartis AG - Ebitda Interest Coverage255,096,620,580.91